IDEXX Laboratories (IDXX) News Today $420.91 -2.74 (-0.65%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Comgest Global Investors S.A.S. Buys 12,353 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)Comgest Global Investors S.A.S. raised its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 36.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 46,308 shares of the company's stock after buying an addiNovember 16 at 10:28 AM | marketbeat.comIDEXX Laboratories Q3 Earnings TranscriptNovember 16 at 7:18 AM | marketbeat.comING Groep NV Lowers Stock Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX)ING Groep NV trimmed its position in IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 9.9% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 16,754 shares of the company's stock after selling 1,848 shares during the period. ING Groep NVNovember 16 at 6:25 AM | marketbeat.comIDEXX Laboratories (NASDAQ:IDXX) shareholders have earned a 10% CAGR over the last five yearsNovember 15 at 11:34 PM | finance.yahoo.comIDEXX Laboratories Target of Unusually Large Options Trading (NASDAQ:IDXX)IDEXX Laboratories, Inc. (NASDAQ:IDXX - Get Free Report) was the target of unusually large options trading on Friday. Stock investors purchased 2,600 put options on the company. This is an increase of 581% compared to the average daily volume of 382 put options.November 15 at 12:19 PM | marketbeat.comKBC Group NV Grows Stock Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX)KBC Group NV increased its stake in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 41.1% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 100,948 shares of the company's stock after purchaNovember 15 at 6:28 AM | marketbeat.comIDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Acquired by Victory Capital Management Inc.Victory Capital Management Inc. lifted its position in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 3.4% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 142,628 shares of the company's stock after buyinNovember 14 at 5:45 AM | marketbeat.comIDEXX Laboratories Board of Directors Member Jonathan W. Ayers ResignsNovember 14 at 5:20 AM | americanbankingnews.comIDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Purchased by Sumitomo Mitsui Trust Group Inc.Sumitomo Mitsui Trust Group Inc. boosted its holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 1.7% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 197,534 shares of the company's stock after acquiring an additional 3,233 sharesNovember 14 at 5:03 AM | marketbeat.com3,241 Shares in IDEXX Laboratories, Inc. (NASDAQ:IDXX) Purchased by Entropy Technologies LPEntropy Technologies LP purchased a new position in IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) during the third quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 3,241 shares of the company's stock, valued at approximately $1,637,000. Several other hedNovember 13, 2024 | marketbeat.comIdexx Laboratories Announces CEO Jonathan Ayers’ ResignationNovember 13, 2024 | markets.businessinsider.comCrystal Rock Capital Management Has $4.55 Million Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX)Crystal Rock Capital Management boosted its holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 90.0% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 9,005 shares of the company's stock after buying anNovember 12, 2024 | marketbeat.comVersor Investments LP Takes Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX)Versor Investments LP bought a new stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 2,720 shares of the company's stock, valued at approximately $1,37November 12, 2024 | marketbeat.comIDEXX Laboratories Q3: Weak End-Market Demand ContinuesNovember 10, 2024 | seekingalpha.comJensen Investment Management Inc. Purchases 2,970 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)Jensen Investment Management Inc. increased its stake in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 58.0% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,090 shares of the company's stockNovember 10, 2024 | marketbeat.comTimesSquare Capital Management LLC Sells 1,910 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)TimesSquare Capital Management LLC decreased its position in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 1.3% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 146,659 shares of the company'November 10, 2024 | marketbeat.comIDEXX Laboratories Inc. stock rises Friday, still underperforms marketNovember 9, 2024 | msn.comVillere ST Denis J & Co. LLC Has $30.76 Million Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX)Villere ST Denis J & Co. LLC cut its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 3.4% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 60,886 shares of the company's stock aNovember 9, 2024 | marketbeat.comFiera Capital Corp Sells 38,574 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)Fiera Capital Corp decreased its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 23.5% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 125,735 shares of the company's stock aNovember 8, 2024 | marketbeat.comIs IDEXX Laboratories (IDXX) The Best Pet Stock To Invest In According To Analysts?November 8, 2024 | uk.finance.yahoo.comBarclays Lowers IDEXX Laboratories (NASDAQ:IDXX) Price Target to $481.00November 8, 2024 | americanbankingnews.comPrincipal Financial Group Inc. Reduces Stock Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX)Principal Financial Group Inc. lowered its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 3.1% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 730,470 shares of the company's stNovember 7, 2024 | marketbeat.comPiper Sandler Keeps Their Hold Rating on Idexx Laboratories (IDXX)November 6, 2024 | markets.businessinsider.comNational Pension Service Purchases 12,647 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)National Pension Service raised its position in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 7.3% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 185,972 shares of the company's stock after acquiringNovember 6, 2024 | marketbeat.comVan ECK Associates Corp Buys 2,367 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)Van ECK Associates Corp raised its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 10.4% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 25,133 shares of the company's stock after purchasingNovember 6, 2024 | marketbeat.comIs It Time to Buy October's Worst-Performing Nasdaq Stocks?November 6, 2024 | fool.comStifel Nicolaus Reaffirms Their Hold Rating on Idexx Laboratories (IDXX)November 5, 2024 | markets.businessinsider.comBTIG Remains a Buy on Idexx Laboratories (IDXX)November 5, 2024 | markets.businessinsider.comA Once-in-a-Decade Opportunity: 1 Super S&P 500 Stock Down 40% to Buy After Its Recent PullbackNovember 5, 2024 | fool.comIDEXX Laboratories, Inc. 2024 Q3 - Results - Earnings Call PresentationNovember 4, 2024 | seekingalpha.comIDEXX Laboratories (NASDAQ:IDXX) Receives "Neutral" Rating from Piper SandlerPiper Sandler restated a "neutral" rating and issued a $435.00 price objective (down previously from $520.00) on shares of IDEXX Laboratories in a research note on Monday.November 4, 2024 | marketbeat.comIDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Sold by Capital Investment Services of America Inc.Capital Investment Services of America Inc. lowered its position in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 6.8% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 38,754 shares oNovember 4, 2024 | marketbeat.comBarclays Cuts IDEXX Laboratories (NASDAQ:IDXX) Price Target to $481.00Barclays lowered their target price on shares of IDEXX Laboratories from $570.00 to $481.00 and set an "overweight" rating on the stock in a research note on Monday.November 4, 2024 | marketbeat.comIDEXX Laboratories, Inc. (NASDAQ:IDXX) Given Consensus Recommendation of "Moderate Buy" by BrokeragesShares of IDEXX Laboratories, Inc. (NASDAQ:IDXX - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the nine brokerages that are currently covering the firm, MarketBeat reports. Two research analysts have rated the stock with a hold recommendation and seven haveNovember 4, 2024 | marketbeat.comIDEXX Laboratories, Inc. (NASDAQ:IDXX) Stake Reduced by New York State Common Retirement FundNew York State Common Retirement Fund trimmed its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 11.3% during the third quarter, according to its most recent disclosure with the SEC. The fund owned 80,934 shares of the company's stock after selling 10,295 shares during the quarterNovember 3, 2024 | marketbeat.comIdexx Laboratories: Strong Financial Performance and Strategic Positioning Justify Buy RatingNovember 2, 2024 | markets.businessinsider.comIDEXX Laboratories Reports Robust Q3 2024 PerformanceNovember 2, 2024 | markets.businessinsider.comIdexx Laboratories Hold Rating: Navigating Uncertain Growth and Market PressuresNovember 2, 2024 | markets.businessinsider.comIDEXX Laboratories Inc (IDXX) Q3 2024 Earnings Call Highlights: Strong EPS Growth Amid Market ...November 2, 2024 | finance.yahoo.comHere’s Why Aristotle Focus Growth Strategy Sold IDEXX Laboratories (IDXX)November 2, 2024 | msn.comIDEXX Laboratories (NASDAQ:IDXX) Releases Quarterly Earnings Results, Beats Expectations By $0.11 EPSIDEXX Laboratories (NASDAQ:IDXX - Get Free Report) released its quarterly earnings results on Thursday. The company reported $2.80 earnings per share for the quarter, beating analysts' consensus estimates of $2.69 by $0.11. The company had revenue of $975.50 million for the quarter, compared to analyst estimates of $980.32 million. IDEXX Laboratories had a net margin of 22.34% and a return on equity of 57.03%. The firm's revenue was up 6.6% on a year-over-year basis. During the same period last year, the firm earned $2.53 earnings per share.November 1, 2024 | marketbeat.comStephens Investment Management Group LLC Lowers Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX)Stephens Investment Management Group LLC reduced its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 7.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 104,900 shares of theNovember 1, 2024 | marketbeat.comBarclays Sticks to Its Buy Rating for Idexx Laboratories (IDXX)November 1, 2024 | markets.businessinsider.comIDEXX Laboratories Inc Reveals Climb In Q3 Income, Beats EstimatesOctober 31, 2024 | markets.businessinsider.comIdexx Laboratories Adjusts Guidance As Q3 Revenue Growth Slows, Analyst Notes Fewer Veterinary Visits, Looks Towards Long-Term GrowthOctober 31, 2024 | benzinga.comIdexx Sees Q3 Revenue BoostOctober 31, 2024 | fool.comIDEXX Laboratories, Inc. (IDXX) Q3 2024 Earnings Call TranscriptOctober 31, 2024 | seekingalpha.comIdexx Laboratories narrows 2024 EPS view to $10.37-$10.53 from $10.31-$10.59October 31, 2024 | markets.businessinsider.comIdexx Laboratories reports Q3 EPS $2.80, consensus $2.68October 31, 2024 | markets.businessinsider.comIDEXX Laboratories (NASDAQ:IDXX) Releases FY24 Earnings GuidanceIDEXX Laboratories (NASDAQ:IDXX) updated its FY24 earnings guidance. The company provided EPS guidance of 10.37-10.53 for the period, compared to the consensus estimate of $10.50. The company also issued revenue guidance of $3.87-3.89 billionillion, compared to the consensus estimate of $3.92 billionillion.October 31, 2024 | marketbeat.com Get IDEXX Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for IDXX and its competitors with MarketBeat's FREE daily newsletter. Email Address The only candlestick pattern worth a darn (Ad)It’s widely known that 80% of daily market action is driven by Wall Street algorithms… Now, most people think of the algorithms are “bad” When in reality, they are neither good nor bad… They are simply programmed to buy and sell certain stocks over and over again… But here is the thing… They are predictable… They typically buy the same stocks at the same levels over and over again… Follow this link here and enter your email address to sign up… IDXX Media Mentions By Week IDXX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IDXX News Sentiment▼1.130.55▲Average Medical News Sentiment IDXX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IDXX Articles This Week▼1910▲IDXX Articles Average Week Get IDEXX Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for IDXX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BSX News MDT News BDX News EW News RMD News DXCM News STE News PODD News HOLX News BAX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IDXX) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IDEXX Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IDEXX Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IDXX Stock Alerts